| |
|
|
CAMBRIDGE, MASS. - Therion Biologics of Cambridge, Mass. is constructing a $5-million, 10,000-sf production facility for two cancer vaccines which are in Phase II clinical trials.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more! Sign Up Now!
|
|
Printer Friendly Version
Send to a Friend
